AGP Executive Report
Last update: 24 minutes agoPatient Safety in Focus: Dr. Soliman Fakeeh Hospital – Riyadh says it has earned the Saudi Patient Safety Center Certificate (Silver level), highlighting safer clinical practices, medication safety, infection prevention, and continuous quality improvement. Healthcare Transformation Skills: King Faisal Specialist Hospital (KFSH) used HLTH Europe 2026 to stress that sustainable change depends on capability building—training, simulation, certification, and team readiness for AI and robotic surgery. Cardio/Neuro Care Tech Watch: A new market outlook projects microcatheters to reach $2.98B by 2035, driven by stroke and cardiovascular intervention demand. Diabetes & Weight-Loss Market Growth: Another report forecasts the global GLP-1 receptor agonist market could hit $95.3B by 2035 as demand for type 2 diabetes and obesity treatments keeps rising. Regional Health Security Context: Saudi Arabia’s Council of Ministers welcomed the US-Iran agreement to end military operations and start negotiations, while reiterating the Kingdom’s emphasis on freedom of navigation in the Strait of Hormuz.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
.jpg)
![[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/7b830788-22b5-4951-ae13-795b8c21bc2d/north-america-glp-1-receptor-agonist-market-size-2025-to-2035-usd-billion-.png)
